行情

AFMD

AFMD

Affimed
NASDAQ

实时行情|Nasdaq Last Sale

5.13
-0.47
-8.39%
盘前: 5.10 -0.03 -0.58% 08:21 03/05 EST
开盘
5.65
昨收
5.60
最高
5.74
最低
5.10
成交量
565
成交额
--
52周最高
7.48
52周最低
1.420
市值
5.39亿
市盈率(TTM)
-8.4126
分时
5日
1月
3月
1年
5年
与罗氏公司(Roche)的指定合作伙伴一起开发可表达EGFR的实体瘤的AFM24组合疗法
Benzinga · 02/03 13:43
与罗氏公司(Roche)的指定合作伙伴一起开发可表达EGFR的实体瘤的AFM24组合疗法
Affimed N.V. (NASDAQ: AFMD) has entered into a clinical research collaboration with Roche Holding AG (OTC: RHHBF) to explore the combination of Affimed's AFM24 with Roche's atezolizumab (Tecentriq) for the treatment of advanced solid epidermal growth facto...
Benzinga · 02/03 13:42
与罗氏公司(Roche)的指定合作伙伴一起开发可表达EGFR的实体瘤的AFM24组合疗法
Affimed N.V. (NASDAQ: AFMD) has entered into a clinical research collaboration with Roche Holding AG (OTC: RHHBF) to explore the combination of Affimed's AFM24 with Roche's atezolizumab (Tecentriq) for the treatment of advanced solid epidermal growth facto...
Benzinga · 02/03 13:42
每日生物技术动向:安进收益,GSK-CureVac疫苗合作,Mallinckrodt FDA决定
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 2) Argenx SE – ADR (NASDAQ: ARGX) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN) Atea Pharmaceuticals Inc (NASDAQ: AVIR...
Benzinga · 02/03 12:31
每日生物技术动向:安进收益,GSK-CureVac疫苗合作,Mallinckrodt FDA决定
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 2) Argenx SE – ADR (NASDAQ: ARGX) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN) Atea Pharmaceuticals Inc (NASDAQ: AVIR...
Benzinga · 02/03 12:31
每日生物技术动向:博士伦健康发布积极的预公告,Acorda简化运营
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12)
Benzinga · 01/13 12:25
Affimed宣布与硅谷银行达成2500万欧元的债务融资协议
Affimed N.V. (NASDAQ:AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it has entered into a debt financing agreement with
Benzinga · 01/11 11:31
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 14)
Benzinga · 2020/12/15 12:52
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解AFMD最新的财务预测,通过AFMD每股收益,每股净资产,每股现金流等数据分析Affimed近期的经营情况,然后做出明智的投资选择。
分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测AFMD价格均价为9.45,最高价位10.82,最低价为7.87。
EPS
机构持股
总机构数: 157
机构持股: 6,413.48万
持股比例: 61.08%
总股本: 1.05亿
类型机构数股数
增持
50
1,217.79万
建仓
36
397.66万
减持
34
556.73万
平仓
0
0
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-3.62%
制药与医学研究
-2.13%
高管信息
Chairman - Supervisory/Independent Director
Thomas Hecht
President/Management Board
Denise Mueller
Chief Executive Officer/Management Board
Adi Hoess
Chief Financial Officer
Angus Smith
Chief Operating Officer/Management Board
Wolfgang Fischer
Chief Scientific Officer/Management Board
Arndt Schottelius
Management Board
Andreas Harstrick
Independent Director/Supervisory Board
Bernhard Ehmer
Independent Director/Supervisory Board
Ulrich Grau
Independent Director/Supervisory Board
Berndt Modig
Independent Director/Supervisory Board
Mathieu Simon
Independent Director/Supervisory Board
Ferdinand Verdonck
Supervisory Board
Annalisa Jenkins
Supervisory Board
Harry Welten
暂无数据
AFMD 简况
Affimed N.V.是一家临床阶段的生物制药公司,专注于发现和开发癌症免疫疗法。该公司开发免疫肿瘤领域的候选产品,代表一种旨在利用身体自身免疫系统对抗肿瘤细胞的癌症研究方法。其产品包括FM13、AFM11、AFM21、AFM22、AFM24、TandAb和Trispecific Abs。它已经开始针对患有霍奇金淋巴瘤患者的AFM13的IIa期临床试验。它还已经开始针对非霍奇金淋巴瘤患者的AFM11的I期临床试验。AFM21正处于临床前开发阶段。作为表皮生长因子受体变异III(EGFRvIII)型/ CD16A NK-cell TandAb的AFM22正处于临床前开发阶段。AFM24是另一种靶向证实的实体瘤靶标EGFR-野生型的CD16A NK-cell TandAb。该公司正在开发用于治疗多发性骨髓瘤的Trispecific Abs,以及用于治疗急性骨髓白血病的CD33/CD3-specific T-cell TandAb。

微牛提供Affimed NV(NASDAQ-AFMD)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的AFMD股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易AFMD股票基本功能。